MARGetuximab Or Trastuzumab (MARGOT)
MARGetuximab Or Trastuzumab (MARGOT)
Active, not recruiting · NCT04425018 · Registry updated 2025-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MARGetuximab Or Trastuzumab (MARGOT) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2025-11-18 | NCT04425018 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| MacroGenics | 12 |
| Translational Breast Cancer Research Consortium | 19 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine Medical Center | Houston | United States | 14 |
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Dana-Farber at Milford | Milford | United States | 4 |
| Dana-Farber at South Shore Hospital | Weymouth | United States | 2 |
| Dana-Farber Brigham Cancer Center - Foxborough | Foxborough | United States | 5 |
| Georgetown University Medical Center | Washington D.C. | United States | 62 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| MedStar Washington Hospital Center | Washington D.C. | United States | 207 |
| Montefiore Medical Center | The Bronx | United States | 79 |
| University of Pittsburgh Medical Center | Pittsburgh | United States | 127 |
| University of Washington Fred Hutchinson Cancer Care | Seattle | United States | 3 |
| UPMC Hillman Cancer Center - Arnold Palmer at Mountain View | Greensburg | United States | 1 |
| UPMC Hillman Cancer Center - Arnold Palmer at Norwin | Irwin | United States | 1 |